These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29529877)

  • 1. Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?
    Muchtar E; Gertz MA; Kumar SK; Lin G; Boilson B; Clavell A; Lacy MQ; Buadi FK; Hayman SR; Kapoor P; Dingli D; Rajkumar SV; Dispenzieri A; Grogan M
    Amyloid; 2018 Jun; 25(2):86-92. PubMed ID: 29529877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin Use in Cardiac Amyloidosis.
    Donnelly JP; Sperry BW; Gabrovsek A; Ikram A; Tang WHW; Estep J; Hanna M
    Am J Cardiol; 2020 Oct; 133():134-138. PubMed ID: 32800294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia.
    Dittrich T; Benner A; Kimmich C; Siepen FAD; Veelken K; Kristen AV; Bochtler T; Katus HA; Müller-Tidow C; Hegenbart U; Schönland SO
    Haematologica; 2019 Jul; 104(7):1451-1459. PubMed ID: 30655373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring.
    Goldsmith YB; Liu J; Chou J; Hoffman J; Comenzo RL; Steingart RM
    Am J Cardiol; 2009 Oct; 104(7):990-4. PubMed ID: 19766769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case series of hospitalized patients with elevated digoxin levels.
    Marik PE; Fromm L
    Am J Med; 1998 Aug; 105(2):110-5. PubMed ID: 9727817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin remains useful in the management of chronic heart failure.
    Dec GW
    Med Clin North Am; 2003 Mar; 87(2):317-37. PubMed ID: 12693728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between digoxin-induced cardiac arrhythmias and serum-digoxin levels (author's transl)].
    Hennersdorf G; Mariss P; Biermann S; Haindl H; Lichtlen P
    Dtsch Med Wochenschr; 1977 Mar; 102(11):381-4. PubMed ID: 66122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recrudescent digoxin toxicity treated with plasma exchange: a case report and review of literature.
    Rajpal S; Beedupalli J; Reddy P
    Cardiovasc Toxicol; 2012 Dec; 12(4):363-8. PubMed ID: 22618329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
    Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
    Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor.
    Rezk T; Lachmann HJ; Fontana M; Sachchithanantham S; Mahmood S; Petrie A; Whelan CJ; Pinney JH; Foard D; Lane T; Youngstein T; Wechalekar AD; Bass P; Hawkins PN; Gillmore JD
    Kidney Int; 2017 Dec; 92(6):1476-1483. PubMed ID: 28729034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of AL amyloidosis presenting with refractory ventricular fibrillation.
    Angsubhakorn N; Agdamag A; Sumransub N; Velangi P; Freund R; Martin CM; Alexy T
    Respir Med Case Rep; 2021; 32():101349. PubMed ID: 33552893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin and the geriatric in-patient. A randomized trial of digoxin versus placebo.
    Boman K
    Acta Med Scand; 1983; 214(5):353-60. PubMed ID: 6362340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical signs and symptoms of toxic serum digoxin levels in neonates.
    Mutlu M; Aslan Y; Kader Ş; Aktürk-Acar F; Dilber E
    Turk J Pediatr; 2019; 61(2):244-249. PubMed ID: 31951334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Digoxin level as a limited drug toxicity indicator in the assessment of post-digitalis arrhythmia].
    Sinkiewicz W; Marzec A; Jankowski A; Hoffmann A
    Wiad Lek; 1994; 47(21-24):808-12. PubMed ID: 8999691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiorgan involvement by amyloid light chain amyloidosis.
    Li G; Han D; Wei S; Wang H; Chen L
    J Int Med Res; 2019 Apr; 47(4):1778-1786. PubMed ID: 30803274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum digoxin concentrations and clinical signs and symptoms of digoxin toxicity in the paediatric population.
    Moffett BS; Garner A; Zapata T; Orcutt J; Niu M; Lopez KN
    Cardiol Young; 2016 Mar; 26(3):493-8. PubMed ID: 25912244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Holter monitoring in detecting digitalis-provoked arrhythmias.
    Goren C; Denes P
    Chest; 1981 May; 79(5):555-8. PubMed ID: 7226934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the appropriateness of serum digoxin concentration measurement in a medical group setting.
    Orrico KB; Wu M; Wilson AR
    J Manag Care Pharm; 2011 Nov; 17(9):695-700. PubMed ID: 22050394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.